Showing results (311-320 of 337) with videos related to

Sort By:
Pageof 34
Critical Care Medicine|March 30, 2018
One-Year Outcomes in Patients With Acute Respiratory Distress Syndrome Enrolled in a Randomized Clinical Trial of Helmet Versus Facemask Noninvasive VentilationBhakti K Patel, Krysta S Wolfe, Erica L MacKenzie, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 22, 2016
Climate change is catchy--but when will it really hurt?N A Sweijd, C Y Wright, A Westwood, et al.
JCO Precision Oncology|September 11, 2020
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic TumorsToby Trahair, Andrew J Gifford, Ashleigh Fordham, et al.
Haematologica|August 16, 2019
DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblastsLaura A Richards, Ashu Kumari, Kathy Knezevic, et al.
Blood|May 4, 2011
ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancerJulie A I Thoms, Yehudit Birger, Sam Foster, et al.
British Journal of Cancer|July 21, 2020
CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcomaAshleigh M Fordham, Jinhan Xie, Andrew J Gifford, et al.
Leukemia|April 9, 2016
MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferationY Huang, J A I Thoms, M L Tursky, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2025
Comparing integrative ventilatory and renal acid-base acclimatization in lowlanders and Tibetan highlanders during ascent to 4,300 mNicole A Johnson, Jessica A Dickenson, Benjamin W L MacKenzie, et al.
Psychological Medicine|May 24, 2019
Observed psychopathology in offspring of parents with major depressive disorder, bipolar disorder and schizophreniaA Sandstrom, L MacKenzie, A Pizzo, et al.
Neuro-Oncology|May 22, 2019
A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastomaEkaterina Pak, Ethan L MacKenzie, Xuesong Zhao, et al.
Pageof 34